MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,097,000 | -8.0% | 42,460 | -26.8% | 0.05% | -31.0% |
| Q3 2016 | $1,193,000 | -62.0% | 57,986 | -43.5% | 0.07% | -60.8% |
| Q2 2016 | $3,139,000 | +123.7% | 102,590 | +173.7% | 0.18% | +86.6% |
| Q1 2016 | $1,403,000 | -16.7% | 37,485 | -16.6% | 0.10% | -4.0% |
| Q3 2015 | $1,685,000 | +73.5% | 44,970 | +57.5% | 0.10% | +83.6% |
| Q2 2015 | $971,000 | -41.1% | 28,553 | -38.7% | 0.06% | -45.5% |
| Q1 2015 | $1,648,000 | -13.4% | 46,545 | -16.6% | 0.10% | -35.3% |
| Q4 2014 | $1,902,000 | -13.3% | 55,829 | -1.9% | 0.16% | +4.7% |
| Q3 2014 | $2,195,000 | +301.3% | 56,922 | +255.8% | 0.15% | +55.2% |
| Q1 2014 | $547,000 | -82.4% | 16,000 | -87.9% | 0.10% | -83.4% |
| Q3 2013 | $3,100,000 | +167.5% | 131,925 | +205.9% | 0.58% | +233.5% |
| Q2 2013 | $1,159,000 | – | 43,129 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 122,428 | $3,618,000 | 3.32% |
| Sensato Investors LLC | 553,505 | $16,356,000 | 2.54% |
| Camber Capital Management LP | 1,500,000 | $44,325,000 | 2.18% |
| S&T BANK/PA | 387,084 | $11,439,000 | 2.04% |
| Taylor Frigon Capital Management LLC | 46,989 | $1,389,000 | 1.08% |
| AIMZ Investment Advisors, LLC | 43,785 | $1,294,000 | 0.94% |
| Matarin Capital Management, LLC | 398,828 | $11,785,367,000 | 0.88% |
| Summit Street Capital Management, LLC | 30,097 | $889,000 | 0.88% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,321,171 | $39,041,000 | 0.77% |
| Millrace Asset Group, Inc. | 45,544 | $1,346,000 | 0.65% |